LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

Search

Palvella Therapeutics Inc

Open

SectorHealthcare

91.49 -0.33

Overview

Share price change

24h

Current

Min

88.76

Max

95.54

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+40.22% upside

News Sentiment

By Acuity

41%

59%

131 / 374 Healthcare

Palvella Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

2 Dec 2025, 17:29 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2 Dec 2025, 16:21 UTC

Earnings

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2 Dec 2025, 16:18 UTC

Earnings

Correction to Scotiabank Quarterly Earnings Buoyed Article

2 Dec 2025, 23:53 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

2 Dec 2025, 22:48 UTC

Earnings

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2 Dec 2025, 22:12 UTC

Market Talk

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2 Dec 2025, 22:03 UTC

Market Talk

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2 Dec 2025, 22:00 UTC

Market Talk

Global Equities Roundup: Market Talk

2 Dec 2025, 22:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2 Dec 2025, 22:00 UTC

Market Talk

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2 Dec 2025, 21:56 UTC

Earnings

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 Dec 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

2 Dec 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 Dec 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 Dec 2025, 21:44 UTC

Earnings

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 Dec 2025, 21:38 UTC

Market Talk

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2 Dec 2025, 21:19 UTC

Earnings

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2 Dec 2025, 20:06 UTC

Market Talk

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2 Dec 2025, 19:55 UTC

Market Talk

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2 Dec 2025, 19:53 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

2 Dec 2025, 19:53 UTC

Market Talk
Earnings

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2 Dec 2025, 19:24 UTC

Market Talk

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2 Dec 2025, 19:06 UTC

Market Talk

Precious Metals Step Back After Silver Sets Record -- Market Talk

2 Dec 2025, 18:27 UTC

Acquisitions, Mergers, Takeovers

Kraken to Acquire Backed Finance AG

2 Dec 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 Dec 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2 Dec 2025, 15:17 UTC

Market Talk

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2 Dec 2025, 14:47 UTC

Market Talk

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2 Dec 2025, 14:38 UTC

Market Talk

Silver Steps Back From Record Levels -- Market Talk

2 Dec 2025, 14:31 UTC

Market Talk
Earnings

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Peer Comparison

Price change

Palvella Therapeutics Inc Forecast

Price Target

By TipRanks

40.22% upside

12 Months Forecast

Average 132.55 USD  40.22%

High 200 USD

Low 70 USD

Based on 11 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

11

Buy

0

Hold

0

Sell

Sentiment

By Acuity

131 / 374 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

$

help-icon Live chat